Skip to main content
Premium Trial:

Request an Annual Quote

Coming Up - Next Month in GT

Premium

Don’t miss these features in the April issue:

Attack on Cancer
In this special issue of Genome Technology, we’ll focus heavily on how the integrated biology arsenal is taking aim at all varieties of cancer, looking at the ways our many technology categories are playing vital roles. From proteomics to bioinformatics, from microarrays to RNAi, from pharmacogenomics to epigenetics, scientists from all avenues of integrated biology are working together in groundbreaking ways to understand, diagnose, and eventually defeat this rampant killer.

 

Inside the FDA
The FDA has taken center stage for many pharma and even academic researchers in this field. We’ll look at what the agency’s guidelines mean for you, show how they’re affecting the field, and introduce you to the newest FDA honchos who are heading up these initiatives.

 

Systems biology roundtable
In an attempt to reach some kind of consensus, our experts discuss the basics of systems biology.

 

 

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.